[{"Assets_0_FY_USD":"1012792000.0","CIK":"1743881","CommonStockSharesIssued_0_FY_shares":"153535084.0","CommonStockSharesOutstanding_0_FY_shares":"147343323.0","Country":"United States","EarningsPerShareBasic_4_FY_USD":"-3.9","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"1594164456.0","MinorityInterest_0_FY_USD":"3412000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":"-497934000.0","NetIncomeLossAvailableToCommonStockholdersBasic_4_FY_USD":"-562539000.0","OfficialName":"BridgeBio Pharma Inc. Common Stock","ProfitLoss_4_FY_USD":"-586454000.0","RevenuesConverted_4_FY_USD":"69716000.0","SP500":null,"Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_FY_USD":"-867002000.0","StockholdersEquity_0_FY_USD":"-870414000.0","Ticker":"BBIO","TreasuryStockSharesConverted_0_FY_shares":"6191761.0","WeightedAverageNumberOfShareOutstandingBasicAndDiluted_4_FY_shares":"144356619.0","filed":"20220225","footnote":null,"form":"10-K","fp":"FY","fy":"2021.0","name":"BRIDGEBIO PHARMA, INC.","period":"20211231","qtrs":"0","uom":"USD"}]